非酒精性脂肪性肝病与高尿酸血症

doi:10.3969/j.issn.1672-5069.2017.03.002

Abstract

Xu Chengfu, Li Youming. Hyperuricemia in patients with nonalcoholic fatty liver disease[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 260-262.

[1] Fan JG.Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol,2013,28(Suppl 1):11-17.
[2] Lonardo A,Loria P,Leonardi F,et al.Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis,2002,34(3):204-211.
[3] Lee S,Jin Kim Y,Yong Jeon T,et al.Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease:a cross-sectional case-control study. Scand J Gastroenterol,2006,41(5):566-572.
[4] Baba T,Amasaki Y,Soda M,et al.Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertens Res,2007,30(9):823-829.
[5] Li Y,Xu C,Yu C,et al.Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol,2009,50(5):1029-1034.
[6] Cai W,Wu X,Zhang B,et al.Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. Arq Bras Endocrinol Metabol,2013,57(8):617-622.
[7] Moon SS.Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. Ann Nutr Metab,2013,62(2):158-163.
[8] Liu PJ,Ma F,Lou HP,et al.Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. Climacteric,2014,17(6):692-699.
[9] Xia MF,Lin HD,Li XM,et al.Renal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middle-aged and elderly Chinese population. Clin Exp Pharmacol Physiol,2012,39(11):930-937.
[10] Liu CQ,He CM,Chen N,et al. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. Sci Rep,2016,[ahead of print].
[11] Cardoso AS,Gonzaga NC,Medeiros CC,et al.Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. J Pediatr (Rio J),2013,89(4):412-418.
[12] Petta S,Camma C,Cabibi D,et al.Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther,2011,34(7):757-766.
[13] Sertoglu E,Ercin CN,Celebi G,et al.The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin Biochem,2014,47(6):383-388.
[14] Liu J,Xu C,Ying L,et al. Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults. Hepatol Res,2016,[ahead of print].
[15] Yoneda M,Thomas E,Sumida Y,et al.Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Biochem,2014,47(12):1138-1139.
[16] Huang JF,Yeh ML,Yu ML,et al.Hyperuricemia inversely correlates with disease severity in Taiwanese nonalcoholic steatohepatitis patients. PLoS One,2015,10(10):e0139796.

Hyperuricemia in patients with nonalcoholic fatty liver disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[2]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[3]	Zhang Lanhua, Shao Qin, Xia Zhenjuan. Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 522-525.
[4]	Huo Huiqin, Gong Xiaohong, Li Zhenghong. Assessment of right atrial and ventricular functions in patients with nonalcoholic fatty liver disease-induced liver cirrhosis by real-time three-dimensional echocardiography and speckle tracking imaging [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 244-247.
[5]	Xie Xiao, Lu Lungen. Noninvasive diagnosis and assessment of patients with nonalcoholic steatohepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 301-306.
[6]	Zhong Yan, Su Shuting, Mi Yuqiang.. Treatment of patients with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 145-148.
[7]	Huang Jiaofeng, Lin Su, Wang Mingfang, et al.. Impact of entecavir therapy on hepatic steatosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 863-867.
[8]	Huang Faguang, Li Xiaocheng, Gong Jianping, et al.. Research on insulin resistance related protein molecules in human liver tissues by comprehensive gene expression profiling analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 872-876.
[9]	Pu Yonglan, Chen Yuanwen, Fan Jiangao.. Gluten intestinal disease and nonalcoholic fatty liver: One case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 981-982.
[10]	Yan Chenli, Wang Jingjing, Wang Jun.. Severity of coronary artery lesions and risk factors in patients with nonalcoholic fatty liver disease complicated by coronary heart disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 737-740.
[11]	Bing Hao, Li Yiling.. Correlation between non-alcoholic fatty liver disease and hepatocellular carcinoma:Fact or fiction [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 821-824.
[12]	Wang Xinwei, Lyu Ke, Sun Xiao, et al. Effect of selective β3-adrenergic receptor agonist on hepatic oxidative stress and liver fibrosis in rats with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 384-387.
[13]	Li Caihong, Lian Lingling, Lu Derong. Preliminary trial of ezetimibe combined with atorvastatin in treatment of patient with nonalcoholic fatty liver disease complicated by coronary heart disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 405-408.
[14]	He Xiaoping, Ran Dongmei, Qing Ling. Improved compliance of life style in patients with nonalcoholic fatty liver disease by family visit based on cross-theretical model of change [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 465-466.
[15]	Zeng Minde. Mechanisms of lipotoxicity in pathogenesis of nonalcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 153-156.